Evidence map›Paper›PMID 33291730›Full record

ArticleNanomaterials (Basel, Switzerland)2020

Fabrication of Anisotropic Cu Ferrite-Polymer Core-Shell Nanoparticles for Photodynamic Ablation of Cervical Cancer Cells.

Shuo-Hsiu Kuo, Po-Ting Wu, Jing-Yin Huang, Chin-Pao Chiu, Jiashing Yu, Mei-Yi Liao

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Engineering copper ferrite (CuFeMicrosystems & nanoengineering · 2026
    Review
  2. Article
  3. Magnetic nanoparticles as promising materials for the future of medicine.Journal of materials science. Materials in medicine · 2026
    Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. [Surface modification of multifunctional ferrite magnetic nanoparticles and progress in biomedicine].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2023
    Review
  13. Article
  14. Review
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Shuo-Hsiu KuoDepartment of Chemical Engineering, National Taiwan University, Taipei 10617, Taiwan.
Po-Ting WuDepartment of Chemical Engineering, National Taiwan University, Taipei 10617, Taiwan.
Jing-Yin HuangDepartment of Applied Chemistry, National Pingtung University, Pingtung 90003, Taiwan.
Chin-Pao ChiuDepartment of Applied Chemistry, National Pingtung University, Pingtung 90003, Taiwan.
Jiashing YuDepartment of Chemical Engineering, National Taiwan University, Taipei 10617, Taiwan.ORCID 0000-0002-0782-2328
Mei-Yi LiaoDepartment of Applied Chemistry, National Pingtung University, Pingtung 90003, Taiwan.
National Pingtung University · TWNational Taiwan University · TW

Funding

National Science Council MOST 109-2113-M-153-001-, MOST 108-2113-M-153-001-, and MOST 109-2221-E-002-101-
6 · The paper itself

Abstract

In this work we developed methylene blue-immobilized copper-iron nanoparticles (MB-CuFe NPs) through a facile one-step hydrothermal reaction to achieve a better phototherapeutic effect. The Fe/Cu ratio of the CuFe NPs was controllable by merely changing the loading amount of iron precursor concentration. The CuFe NPs could serve as a Fenton catalyst to convert hydrogen peroxide (H

Indexed as

bimetallic nanoparticlescancer treatmentFenton reactionphotodynamic therapyreactive oxygen speciessuperparamagnetic nanoparticles

Identifiers

PMID33291730
PMCPMC7761902
OpenAlexW3109683385

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.